Literature DB >> 19887535

Understanding frailty.

Walter Bortz.   

Abstract

Mesh：

Year:  2009        PMID： 19887535     DOI： 10.1093/gerona/glp162

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN： 1079-5006            Impact factor:   6.053


× No keyword cloud information.
  7 in total

1.  Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men.

Authors:  Keri N Althoff; Lisa P Jacobson; Ross D Cranston; Roger Detels; John P Phair; Xiuhong Li; Joseph B Margolick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-14       Impact factor: 6.053

2.  A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men.

Authors:  Loic Desquilbet; Lisa P Jacobson; Linda P Fried; John P Phair; Beth D Jamieson; Marcy Holloway; Joseph B Margolick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-06-30       Impact factor: 6.053

Review 3.  Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs.

Authors:  Damani A Piggott; Kristine M Erlandson; Kevin E Yarasheski
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

Review 4.  Inflammation Strikes Again: Frailty and HIV.

Authors:  Stephanie M Fukui; Damani A Piggott; Kristine M Erlandson
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

Review 5.  The Use of Figurative Language to Describe Frailty in Older Adults.

Authors:  B Buta; D Leder; R Miller; N L Schoenborn; A R Green; R Varadhan
Journal:  J Frailty Aging       Date:  2018

6.  The patterns of health care utilization by elderly Europeans: frailty and its implications for health systems.

Authors:  Stefania Ilinca; Stefano Calciolari
Journal:  Health Serv Res       Date:  2014-08-19       Impact factor: 3.402

7.  Prevalence and factors associated with frailty in an older population from the city of Rio de Janeiro, Brazil: the FIBRA-RJ Study.

Authors:  Virgílio Garcia Moreira; Roberto Alves Lourenço
Journal:  Clinics (Sao Paulo)       Date:  2013-07       Impact factor: 2.365
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.